# An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses

> **NCT00377273** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 250 (—)

## Conditions studied

- Actinic Keratoses

## Interventions

- **DRUG:** fluorouracil cream 0.5%

## Key facts

- **NCT ID:** NCT00377273
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** 2005-10
- **Target enrollment:** 250 (—)
- **Last updated:** 2008-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00377273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00377273, "An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00377273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*